SCHEMBL28198548

SCHEMBL28198548

N#Cc1ccnc(-c2cccnc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.56
CYP1A2 P05177 8/20 0.49
CYP3A4 P08684 7/20 0.49
ALDH1A1 P00352 5/20 0.49
CYP2D6 P10635 4/20 0.49
HSD17B10 Q99714 4/20 0.49
CYP11B2 P19099 2/20 0.49
LMNA P02545 2/20 0.49
MAPK1 P28482 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
CYP17A1 P05093 1/20 0.49
CYP11B1 P15538 1/20 0.49
ALOX15 P16050 3/20 0.48
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CLK4 Q9HAZ1 7/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6131064 0.82 ABCG2 (0.53) CYP1A2CYP3A4ALDH1A1CYP2D6HSD17B10
SCHEMBL30629328 0.79 ABCG2 (0.49) LMNAMAPTKMT2ARXFP1
SCHEMBL20743783 0.78 ABCG2 (0.36) CLK4
SCHEMBL4022715 0.75 CYP2A6 (0.57) CYP2A6CYP1A2CYP3A4ALDH1A1CYP11B2
SCHEMBL30297896 0.75 CYP11B2 (0.54) CYP2A6CYP1A2CYP3A4ALDH1A1CYP11B2
SCHEMBL29699104 0.75 CYP2A6 (0.57) CYP2A6CYP1A2CYP3A4ALDH1A1CYP11B2
SCHEMBL9514248 0.74 CLK4 (0.46) CYP1A2CYP3A4ALDH1A1CYP2D6HSD17B10
SCHEMBL18404929 0.74 CYP11B2 (0.62) CYP2A6CYP1A2CYP3A4ALDH1A1CYP2D6
SCHEMBL15972704 0.74 CYP2A6 (0.62) CYP2A6CYP1A2CYP3A4ALDH1A1CYP2D6
SCHEMBL4631413 0.74 CYP2A6 (0.62) CYP2A6CYP1A2CYP3A4ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107667106-A 2 (base of Pyrazolopyridine 3) pyrimidine derivatives as JAK inhibitor 阿尔米雷尔有限公司 2018-02-06 CN disclosed